SUMMARY Among 40 hospitalized infants and children with cytomegalovirus infection, 14 (35 %) had interstitial pneumonitis, 4 (10%) had wheezing or tachypnoea but without x-ray evidence of classical interstitial pneumonia, the remaining 22 (55 %) were free of pulmonary involvement. Most patients had tachypnoea and nonproductive cough of varying durations: those with underlying pulmonary pathology tended to have persistent and prolonged respiratory symptoms. Mortality and severity of the lung disease were related to the underlying immunodeficiency or concomitant pulmonary process.
Clinical presentations of cytomegalovirus (CMV) infection encompass a broad spectrum of symptoms and signs ranging from asymptomatic disease to lethal congenital infection (Hanshaw et al., 1965; Starr and Gold, 1968) . The most common features of congenital infection include hepatosplenomegaly, jaundice, petechiae, low birthweight, and microcephaly (Overall and Glasgow, 1970) . Acquired CMV infections are often seen in patients with altered host resistance (Hill et al., 1964; Cangir and Sullivan, 1966; Sutton et al., 1967; Neiman et al., 1973) , but these infections may also occur in normal hosts (Klemola et al., 1969; Jordan et al., 1973) . Various manifestations of acquired CMV infection have been reported, e.g. infectious mononucleosis-like syndrome, hepatitis, postperfusion syndrome, etc. (Hanshaw et al., 1965; Embil et al., 1968; Klemola et al., 1969 Klemola et al., , 1972 Jordan et al., 1973) .
Pneumonia occurs not infrequently in patients dying from CMV infection both in congenital disease (Medearis, 1964; McCracken et al., 1969) and in hosts with altered immunity (Hill et al., 1964; Rifkind et al., 1967) . However, the relative incidence and clinical course of pneumonia associated with CMV infection in living human hosts have not been well delineated. Follow-up studies of CMV pulmonary pathology are also lacking. This report describes our experiences concerning the clinical and virological aspects of pulmonary involvement with CMV infection in children. asthma, probable aspiration pneumonia, and congestive heart failure. All 4 patients had wheezing or tachypnoea of less than one week duration. Chest x-rays of these patients showed air trapping, increased lung marking, or consolidation. Except for CMV no other viral or bacterial pathogens were isolated from these patients. In addition to the recovery of CMV from the urine specimens, all 4 patients had positive isolation of CMV from the throat swabs.
Course and outcome of pulmonary involvement. The clinical course and prognosis of pulmonary involvement with CMV were variable. 3 patients (Cases 5, 8, 13) who had underlying immune disorders or leukaemia died of pulmonary complications within 3 months. 3 patients (Cases 2, 6, 10), who had coexisting pulmonary pathology, developed persistent pneumonia or pulmonary fibrosis; one of these (Case 2) died of the pulmonary complication. The remaining 12 patients without underlying disease all, except 2 (Cases 7, 12), had a relatively mild respiratory symptom. The x-ray evidence of pulmonary involvement resolved in less than 8 weeks. The prognosis for these patients was good. Case 12 had no detectable underlying disease but has had persistent massive hepatosplenomegaly, chronic pneumonia, and has excreted CMV in his urine and throat for more than 37 months. Case 7 had sudden infant death syndrome and showed no underlying disease at necropsy except for the extensive interstitial pneumonitis (Fig. 4) .
Virus isolation. CMV was repeatedly isolated from the urine or throat swabs in most patients. In Case 12, 90% (89/99) of urine specimens and 80% (4/5) of throat swabs were positive for CMV for over 37 months. Urine was the best source for virus isolation. Among 36 patients from whom urines were submitted for culture, all except one had CMV isolated. Follow-up of urine culture for CMV indicated that several of these children continued to excrete CMV for over one year (Table 1) . Excretion of CMV from the upper respiratory tract appeared to correlate with the presence or absence of pulmonary involvement (Table 3) . The rates of CMV recovery from throat swabs were 92% (13/14) in children with pulmonary involvement and 22% (2/9) in children without. The virus was recovered from 2 patients (Cases 7, 13) in the lung tissues at necropsy. (3) 0% (0) disorders Death associated 28% (5) 0% (0) with pulmonary failure Hepatomegaly 88% (16) 54% (12) No. in parentheses represents number of patients. In some patients only one specimen (urine, throat swab, or lung tissues) was submitted for virus isolation. Some patients had positive CMV isolation in the urine and negative in the throat swab or vice versa.
Patients without pulmonary involvement. Of 22 children with CMV infection but no respiratory complaints, none had malignancies or diseases which altered host resistance. The primary reasons for evaluating these patients were developmental delay (6), unexplained hepatomegaly (4), seizures (4), congenital heart disease (3), haematuria (2), thrombocytopenia (1), periorbital oedema (1), and diarrhoea (1). The characteristics of children with and without pulmonary involvement in CMV infection are summarized in Table 3 . Patients with pulmonary manifestations more often had underlying immunodeficiency or lung pathology. Furthermore, the incidence of hepatomegaly was higher, and other systemic manifestations were also more common in these patients. The mortality rate was 28 % in those with pulmonary involvement; none of the 22 patients without pulmonary symptoms died.
Discussion
Pulmonary findings associated with CMV infection may be manifested as interstitial pneumonitis or other nonspecific symptoms (e.g. bronchiolitis, asthma, respiratory distress of the newborn, or atelectasis). Interstitial pneumonitis of varying severity is the most common manifestation. Our findings have confirmed and extended the earlier reports of pneumonia with CMV infection (Hill et al., 1964; Medearis, 1964; Rifkind et al., 1967; McCracken et al., 1969; Klemola et al., 1972) . Documentation of CMV infection and pulmonary involvement was made by isolation of the virus and by histopathological changes from lung biopsy or necropsy in some cases. In the majority of the cases the diagnosis was made by clinical and x-ray findings. The high incidence (92%) of CMV recovery from throat swabs of patients with pulmonary complaints and low (22 %) recovery from patients with no pulmonary symptoms provide further indirect evidence of the association of CMV and the pulmonary pathology, though this association is not well defined. In an earlier report (McCracken et al., 1969) it was found that pneumonia occurred in approximately 25 % of infants with congenital cytomegalic inclusion disease. Among 40 children with CMV infection in our series, 14 (35%) had interstitial pneumonitis, 4 (10%) had respiratory symptoms without x-ray evidence of interstitial pneumonia, and the remaining 22 (55%) were free of pulmonary involvement. (Our cases were selected from hospitalized infants and children who presented with clinical features compatible with CMV infection or other diagnositic problems.)
Host factors seem to play an important role in the clinical course of pulmonary pathology in CMV infection. The mortality and prognosis of pulmonary disease with CMV were related to the underlying disease. The respiratory symptoms observed in patients without underlying disease were relatively mild and were self limited. On the other hand, pulmonary involvement of CMV infection in immunologically suppressed patients had a poor prognosis and patients frequently died of the respiratory complications. The grave consequences of lung involvement of CMV infection in these patients have been well recognized (Cangir and Sullivan, 1966; Rifkind et al., 1967; Neiman et al., 1973) . Additionally, CMV infection was seen in a group of patients who had normal immunological functions but had suffered a significant pulmonary insult during the newborn period or had an associated chronic respiratory problem. These patients tended to have a protracted clinical course of respiratory symptoms and persistent x-ray changes suggestive of pulmonary fibrosis. The role of CMV in these processes is difficult to determine: damage to the local defence mechanisms in the lungs may have contributed to the persistent infection and delayed resolution of the infiltrates. 
